Evaluating the effectiveness and safety of fixed-dose combinations for treating essential hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data on the effects and side effects of single-pill combinations of fimasartan/amlodipine or fimasartan/amlodipine/hydrochlorothiazide over a 12-week period. It will involve approximately 600 medical institutions and will follow participants for up to 2 years to assess long-term blood pressure control and major cardiovascular events. Participants will be enrolled based on their diagnosis of essential hypertension and will provide informed consent for data collection. The study will gather demographic information, vital signs, medication details, and any adverse reactions related to the treatments.

Why it matters

Who can join: the full rules

* Inclusion Criteria:

  1. Patients who voluntarily consent on the informed consent form and understand the study's purpose, methods, and so on
  2. Males and females over the age of 19
  3. Patients who have been diagnosed with essential hypertension and plan to be treated with fimasartan/amlodipine or fimasartan/amlodipine/hydrochlorothiazide

     If the patient is applicable, one of the following;
     * If the patients have severe hypertension, stage 2 or higher(sit SBP ≥ 160 mmHg or sit DBP ≥ 100 mmHg), or high-risk hypertension (The cardiovascular risk score of the 2018 hypertension treatment guidelines by the Korean Society of Hypertension is applied.) The patients have never been treated with antihypertensive drugs for essential hypertension.
     * If the patients are on concomitant administration of fimasartan/amlodipin and hydrochlorothiazide for essential hypertension or, If the patients are on concomitant administration of a fimasartan/hydrochlorothiazide combination and amlodipine for essential hypertension
     * If the patients have a blood pressure of sitSBP ≥ 140 mmHg or sitDBP ≥ 90 mmHg even though they have been treated with antihypertensive drugs for essential hypertension
  4. The patients who understand this study and are available to participate in this study until the end of the study period with a cooperative attitude.
* Exclusion Criteria:

  1. The patients who are suspected of having secondary hypertension or confirmed to have secondary hypertension
  2. The patients who are contraindicated to taking fimasartan complex according to the drug labelling
  3. The patients who are currently participation in another clinical trials (Drugs or medical devices) The patients who took an investigational drug within 12 weeks of the enrollment date

     However, the following patients can participate in this study:

     The patients who are currently enrolled in non-interventional clinical studies or who are being followed up on after the administration of investigational drugs has ended.
  4. The patients who are not suitable for this study by the investigators

Where it's running

• Seoul National University Bundang Hospital
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: MyungSook Hong
• Email: mshong@boryung.co.kr
• Phone: +8227088238

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effect of Songling Xuemaikang Capsules on mild hypertension

  This study tests whether Songling Xuemaikang Capsules can help people with mild high blood pressure improve their heart and blood vessel health compared to a lifestyle change or a placebo.

  Recruiting Phase 4 Xiyuan Hospital of China Academy of Chinese Medical Sciences · Beijing, Beijing Municipality and 4 other locations · NCT06093932

• Mobile health program to manage hypertension in rural areas

  This study tests a home-based program that helps people in rural areas with high blood pressure by providing personalized coaching and health education to see if it improves their health.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT05546931

• Exploring the Benefits of Natural Medicine and Vitamin IV Therapy

  This study is testing whether herbal medicine and vitamin IV therapy can help improve health and manage chronic conditions like anxiety, fibromyalgia, and arthritis.

  Recruiting The Essence of Integrative Health and Medicine Practice · Dover, Delaware · NCT05067998

• Using advanced imaging to analyze retinal vascular diseases

  This study is testing new imaging techniques to see how they can help doctors understand and track the progress of retinal diseases like diabetic retinopathy in both healthy people and those affected by these conditions.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT04505618

• Mobile app-based telecare system for hypertension management in China and Argentina

  This study is testing a new mobile app to help people with high blood pressure in China and Argentina manage their condition better alongside regular doctor visits.

  Recruiting at 7 sites Istituto Auxologico Italiano · Bahía Blanca and 7 other locations · NCT03206814

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.